Who
In numbers
- Trades disclosed
- 19
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 31 Dec 2023
- Last trade
- 30 Sep 2026
- Last filed
- 2 Oct 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Sep 2026filed 2 Oct 2026 | ABBV AbbVieoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $15K59 at $261.59 | filing |
| 30 Jun 2026filed 2 Jul 2026 | ABBV AbbVieoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $16K62 at $251.64 | filing |
| 30 Jun 2026filed 2 Jul 2026 | ABBV AbbVieoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $16K62 at $251.64 | filing |
| 8 May 2026filed 12 May 2026 | ABBV AbbViePharmaceuticals | SEC FORM 4 Code A | —1,118 at $0.00 | filing |
| 8 May 2026filed 12 May 2026 | ABBV AbbViePharmaceuticals | SEC FORM 4 Code A | —1,118 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | ABBV AbbVieoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $15K71 at $217.49 | filing |
| 31 Mar 2026filed 2 Apr 2026 | ABBV AbbVieoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $15K71 at $217.49 | filing |
| 31 Dec 2025filed 5 Jan 2026 | ABBV AbbVieoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $16K68 at $228.49 | filing |
| 31 Dec 2025filed 5 Jan 2026 | ABBV AbbVieoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $16K68 at $228.49 | filing |
| 30 Sep 2025filed 2 Oct 2025 | ABBV AbbVieoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $16K67 at $231.54 | filing |
| 30 Jun 2025filed 2 Jul 2025 | ABBV AbbVieoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $15K81 at $185.62 | filing |
| 9 May 2025filed 13 May 2025 | ABBV AbbViePharmaceuticals | SEC FORM 4 Code A | —1,203 at $0.00 | filing |
| 31 Mar 2025filed 2 Apr 2025 | ABBV AbbVieoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $15K71 at $209.52 | filing |
| 31 Dec 2024filed 3 Jan 2025 | ABBV AbbVieoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $15K84 at $177.70 | filing |
| 30 Sep 2024filed 2 Oct 2024 | ABBV AbbVieoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $15K75 at $197.48 | filing |
| 30 Jun 2024filed 2 Jul 2024 | ABBV AbbVieoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $15K87 at $171.52 | filing |
| 3 May 2024filed 7 May 2024 | ABBV AbbViePharmaceuticals | SEC FORM 4 Code A | —1,322 at $0.00 | filing |
| 31 Mar 2024filed 2 Apr 2024 | ABBV AbbVieoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $15K82 at $182.10 | filing |
| 31 Dec 2023filed 3 Jan 2024 | ABBV AbbVieoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $9,91864 at $154.97 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.